高通(QCOM.US)溢價96%以24億美元併購英國同業Alphawave
美國晶片商高通(QCOM.US)同意以24億美元現金收購英國同業Alphawave,每股作價2.48美元或1.83英鎊,較消息公佈前收市價0.94英鎊溢價96%。股東可選擇收取高通股份,每股可換取0.01662股新發行高通股票,或0.00964股新發行A系列高通可兌換證券。該等可兌換證券4年鎖定期內不可轉讓,將於16個季度釋放日期兌換爲高通股票。
收購需獲Alphawave股東和法院批準,以及包括南韓和加拿大在內的司法管轄區監管許可,預計明年第一季完成。高盛國際及BMO資本市場於收購中提供財務建議。
Alphawave在2021年於倫敦證券交易所上市,去年收入5.155億美元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.